BERLIN (Reuters) – German federal and state health ministries agreed that from Wednesday AstraZeneca’s COVID-19 vaccine can be used for people aged 60 and older following further reports of a rare brain blood disorder, a document on their agreement showed.
Acting on advice from Germany’s vaccine committee, known as STIKO, the health ministries also agreement the Anglo-Swedish firm’s vaccine could be used for high-risk patients aged below 60.
(Writing by Paul Carrel; Editing by Maria Sheahan)
